Atlantia Clinical Trials

Executive Summary

Atlantia Clinical Trials is a private clinical research organization (CRO) headquartered in Cork, Ireland, founded in 2011. The company specializes in providing clinical trial services across diverse product categories including nutraceuticals, medical devices, pharmaceuticals, and cosmetics. With operational capabilities in both Europe and the United States, Atlantia serves as a Contract Research Organization (CRO) for companies seeking to conduct clinical studies in these regions. Its focus on nutraceuticals and cosmetics differentiates it from many CROs that concentrate primarily on pharmaceuticals, allowing it to capture a specialized segment of the clinical trials market. The company's broad geographical presence and expertise in multiple product areas position it as a versatile partner for sponsors ranging from small startups to established firms. As a private entity, Atlantia does not publicly disclose detailed financials or stage of development, but its long-standing presence since 2011 suggests operational stability. The growing demand for clinical evidence in nutraceuticals and cosmetics, driven by regulatory requirements and consumer awareness, presents expansion opportunities. However, the CRO market is highly competitive, and Atlantia's ability to scale and differentiate will depend on its service quality, regulatory expertise, and client relationships. Future growth may be fueled by expanding into new therapeutic areas or strengthening its US presence. While no specific upcoming catalysts are public, the company's niche specialization in non-traditional product categories could attract partnerships or acquisitions.

Upcoming Catalysts (preview)

• Q1 2027New Major Partnership or Contract Win40% success
• Q2 2027Expansion of US Operations or New Facility35% success
• Q4 2026Regulatory Approval Milestone for a Client Product30% success